Universe Pharmaceuticals Inc. has addressed several key questions from its shareholders concerning the upcoming annual general meeting. Shareholders inquired why they received the proxy statement, to which the company explained it is for the annual general meeting scheduled for August 26, 2025. Another question addressed was what shareholders should do next, with the company advising them to vote their shares promptly as per the instructions on the proxy card or voting instruction form. Additionally, shareholders asked about obtaining the 2024 Annual Report, which the company noted is available on its website under the "SEC Filings" section, avoiding the expenses of mailing physical copies. The full document can be accessed through the link below.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.